EXAS
EXAS
NASDAQ · Biotechnology

Exact Sciences Corp

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$104.91
+0.99 (+0.95%)
As of May 8, 9:40 PM ET ·
Analyst Consensus
Hold
29
Analysts
High
Coverage
Buy 8 28%
Hold 21 72%
Sell 0 0%
Price Target
Analyst Price Target +24.6% upside
Low Target $80.73
Average Target $130.71
High Target $205.54
Current Price $104.91
Current
$104.91
Target
$130.71
$80.73 $130.71 avg $205.54
Scenario Analysis
Bear Case
$80.73
-23.0%
Low target
Base Case
$130.71
+24.6%
Avg target
Bull Case
$205.54
+95.9%
High target
Risk/Reward
4.2x
Highly favorable
Price in Context
52-Week High
$104.98
-0.1% from high
52-Week Low
$38.81
+170.3% from low
50-Day SMA
$102.19
+2.7% vs SMA
200-Day SMA
$69.24
+51.5% vs SMA
RSI (14)
74.6
Overbought
Target vs 52W High
$130.71
+24.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 72% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 26 96% $143.40 +41.5%